| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
4- fluorobenozyl- glutamyl- cyclo(arginyl- glycyl- aspartyl- tyrosyl- lysyl)2
1
relevant articles (0 outcomes,
0 trials/studies)
found for this Bio-Agent
Description: used to image alphaVbeta3 integrin via PET; structure in first source
Also Known As:18F-FB-E(c(RGDyK))2; 18F-FRGD2; FB-E(c(RGDYK))2
Bio-Agent Context: Research Results
Experts
| 1. | Tseng, Jeffery R: 1 article (01/2006) |
| 2. | Gambhir, Sanjiv S: 1 article (01/2006) |
| 3. | Wu, Yun: 1 article (01/2006) |
| 4. | Chen, Xiaoyuan: 1 article (01/2006) |
| 5. | Zhang, Xianzhong: 1 article (01/2006) |
| 6. | Cai, Weibo: 1 article (01/2006) |
| 7. | Xiong, Zhengming: 1 article (01/2006) |
Related Diseases
| 1. | Neoplasms (Cancer)
01/01/2006
- "Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2."
Get all the results and reference details, order at left... |
| 1 Diseases and 1 more articles analyzed in the Research Interface, order at left... | |
Related Drugs and Biologics
| 1. | Integrin alphaVbeta3
|
| 1 Drugs and Important Bio-Agents and 1 more articles analyzed in the Research Interface, order at left... | |
Research Interface
- Unlimited Disease, Drug and Therapy Search
- 2 clicks from Disease to Drug to Evidence
- Trial References
- All the Positive Outcomes
- Detailed Relationship Timeline Charts
- Full Article Reference Details
- Includes Mobile Interface Subscription
- One-click to FDA Products/Patents
- Request Institution License details >>
| Price: | $490.00 access via web interface, 1 year subscription |
Mobile Interface
- Access from any web enabled PDA or Phone
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Full Article Reference Details
- Try Mobile Interface >>
| Price: | $45.00 access via "curehunter.com/m", 1 year subscription |